Needham & Company LLC Cuts Viridian Therapeutics (NASDAQ:VRDN) Price Target to $36.00
Viridian Therapeutics (NASDAQ:VRDN – Free Report) had its price objective lowered by Needham & Company LLC from $38.00 to $36.00 in a research note released on Wednesday,Benzinga reports. The firm currently has a buy rating on the stock. Separately, HC Wainwright reissued a “buy” rating and issued a $34.00 price objective on shares of Viridian […]
Viridian Therapeutics (NASDAQ:VRDN – Free Report) had its price objective lowered by Needham & Company LLC from $38.00 to $36.00 in a research note released on Wednesday,Benzinga reports. The firm currently has a buy rating on the stock. Separately, HC Wainwright reissued a “buy” rating and issued a $34.00 price objective on shares of Viridian […]
